Fig. 1 · Structure
Documents & Downloads
Bempedoic acid-d4
ATP-citrate lyase (ACL) Inhibitor
Bempedoic acid-d4 is a deuterated form of Bempedoic acid, an inhibitor of ATP-citrate lyase (ACL). This compound plays a critical role in lipid metabolism by activating AMP-activated protein kinase (AMPK), which is integral for cellular energy homeostasis. Bempedoic acid-d4 is particularly useful in research related to metabolic disorders and cardiovascular health, providing insights into the mechanisms of ACL inhibition and AMPK activation.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2408131-70-2 |
| Applications | ATP-citrate lyase (ACL) Inhibitor |
| Formula | C19H32D4O5 |
| Molecular Weight | 348.51 |
| Synonyms | ETC-1002-d4; ESP-55016-d4 |
| SMILES | OC(C(C)(C)CCCCC([2H])([2H])C(O)C([2H])([2H])CCCCC(C)(C)C(O)=O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.